Bessemer Group Inc. Has $225.56 Million Position in UnitedHealth Group Incorporated $UNH

Bessemer Group Inc. cut its position in UnitedHealth Group Incorporated (NYSE:UNH) by 57.9% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 723,021 shares of the healthcare conglomerate’s stock after selling 994,079 shares during the period. Bessemer Group Inc. owned 0.08% of UnitedHealth Group worth $225,560,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in the company. Pasadena Private Wealth LLC grew its stake in shares of UnitedHealth Group by 16.3% in the 2nd quarter. Pasadena Private Wealth LLC now owns 1,068 shares of the healthcare conglomerate’s stock valued at $333,000 after buying an additional 150 shares during the period. Banco Santander S.A. grew its stake in shares of UnitedHealth Group by 63.5% in the 2nd quarter. Banco Santander S.A. now owns 84,937 shares of the healthcare conglomerate’s stock valued at $26,498,000 after buying an additional 32,981 shares during the period. OVERSEA CHINESE BANKING Corp Ltd lifted its position in UnitedHealth Group by 15.3% in the 2nd quarter. OVERSEA CHINESE BANKING Corp Ltd now owns 52,573 shares of the healthcare conglomerate’s stock valued at $16,374,000 after acquiring an additional 6,969 shares in the last quarter. Delta Investment Management LLC lifted its position in UnitedHealth Group by 298.1% in the 2nd quarter. Delta Investment Management LLC now owns 27,002 shares of the healthcare conglomerate’s stock valued at $8,424,000 after acquiring an additional 20,220 shares in the last quarter. Finally, New Hampshire Trust lifted its position in UnitedHealth Group by 14.1% in the 2nd quarter. New Hampshire Trust now owns 937 shares of the healthcare conglomerate’s stock valued at $292,000 after acquiring an additional 116 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

UNH has been the topic of several recent research reports. KeyCorp raised their price target on shares of UnitedHealth Group from $350.00 to $400.00 and gave the company an “overweight” rating in a research report on Wednesday, October 8th. Wells Fargo & Company raised their price target on shares of UnitedHealth Group from $267.00 to $400.00 and gave the company an “overweight” rating in a research report on Tuesday, October 7th. Royal Bank Of Canada dropped their target price on shares of UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating on the stock in a research report on Wednesday, July 30th. Weiss Ratings raised shares of UnitedHealth Group from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Friday. Finally, Baird R W cut shares of UnitedHealth Group from a “hold” rating to a “strong sell” rating in a research report on Thursday, July 31st. Eighteen analysts have rated the stock with a Buy rating, eight have given a Hold rating and three have given a Sell rating to the company. According to MarketBeat, UnitedHealth Group currently has an average rating of “Moderate Buy” and an average price target of $385.13.

UnitedHealth Group Trading Up 0.6%

NYSE:UNH opened at $362.78 on Monday. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The stock has a market capitalization of $328.56 billion, a PE ratio of 15.72, a price-to-earnings-growth ratio of 2.34 and a beta of 0.47. The firm’s 50 day moving average is $338.43 and its 200 day moving average is $335.78. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business had revenue of $111.62 billion during the quarter, compared to analysts’ expectations of $111.75 billion. During the same quarter in the prior year, the firm posted $6.80 earnings per share. The firm’s quarterly revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were paid a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a yield of 2.4%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s payout ratio is currently 38.30%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.